Author:
Zhao Jianjun,Cai Jianqiang,Bi Xinyu
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Shewchuk LD, Baracos VE, Field CJ. Reduced splenocyte metabolism and immune function in rats implanted with the morris hepatoma 7777. Metabolism. 1996;45:848–855.
2. Sugawara Y, Yamamoto J, Shimada K, et al. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J AM Coll Surg. 2000; 190:446–450.
3. Tanoue K, Okita K, Akahoshi T, et al. Laparoscopic splenectomy for hematologic diseases. Surgery. 2002;131: S318–323.
4. Shimada M, Hashizume M, Shirabe K, et al. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism.Performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc. 2000;14:127–130.
5. Takayama T, Makuuchi M, Yamazaki S, et al. The role of splenectomy in patients with hepatocellular carcinoma and hypersplenism as an aid to hepatectomy. Nippon Geka Gakkai Zasshi. 1989; 90:1043–1048.